Content about Norfloxacin

June 6, 2011
FDA issues statement on E. coli outbreak in Europe

The Food and Drug Administration on Friday addressed the current outbreak of E. coli O104 in Europe.

SILVER SPRING, Md. — The Food and Drug Administration on Friday addressed the current outbreak of E. coli O104 in Europe.

The U.S. regulatory agency said that it has been in "routine contact" with the Centers of Disease Control and Prevention and the European Union to monitor the current outbreak of E. coli O104 and to track any illnesses in the United States that may be related to the outbreak.

July 14, 2010
Joint FDA advisory committee weighs in on fate of Avandia

A joint advisory committee of the Food and Drug Administration has voted to recommend allowing...

May 26, 2010
FDA to keep a close eye on McNeil operations

According to prepared testimony immediately posted online before members of the Committee on Oversight and...

WASHINGTON According to prepared testimony immediately posted online before members of the Committee on Oversight and Government Reform convened its “Johnson & Johnson Recall of Children’s Tylenol and other Children’s Medicines” hearing Thursday morning, J&J may be under scrutiny for more than the 40 varieties of over-the-counter infant’s and children’s liquid medicines recalled April 30.

May 17, 2010
FDA 'actively pursuing' McNeil Consumer Healthcare

The Food and Drug Administration on Monday posted a media update to its Web page...